Assessing the Role of Selenium Levels and Helicobacter pylori Infection in Gastric Intestinal Metaplasia: A Histopathological Study

Abstract

Assessing the Role of Selenium Levels and Helicobacter pylori Infection in Gastric Intestinal Metaplasia: A Histopathological Study

Abstract

Purpose: Gastric intestinal metaplasia (IM) is a recognized premalignant lesion in the Correa cascade and a key risk factor for gastric adenocarcinoma. Selenium, an essential trace element with antioxidant and immunomodulatory properties, has been implicated in gastric carcinogenesis, but its association with intestinal metaplasia remains incompletely understood. Material and Methods: This cross-sectional observational study included 114 adult patients who underwent diagnostic upper gastrointestinal endoscopy. Gastric biopsy specimens were evaluated for intestinal metaplasia and atrophy according to the updated Sydney System. Logistic regression analyses were performed to identify factors associated with intestinal metaplasia. Results: Gastric intestinal metaplasia was identified in 23 patients (20.2%). Patients with and without IM were comparable in terms of age, sex, and Helicobacter pylori prevalence. Mean serum selenium levels did not differ significantly between groups; however, selenium deficiency was more frequent in patients with IM (34.8% vs. 12.1%, p=0.024). In multivariable analysis, selenium deficiency was independently associated with intestinal metaplasia (OR 4.01, 95% CI 1.37–11.74, p=0.011), whereas Helicobacter pylori infection was not. Conclusion: Impaired selenium status may contribute to early gastric mucosal alterations and could represent a modifiable risk factor in gastric precancerous conditions.

Keywords

• intestinal metaplasia
• selenium levels
• helicobacter pylori
• gastric cancer
• gastrointestinal biomarkers

References

1. Danpanichkul P, Suparan K, Tothanarungroj P, et al. Epidemiology of gastrointestinal cancers: a systematic analysis from the Global Burden of Disease Study 2021. Gut 2024;74:26-34.
2. Pan KF, Li WQ, Zhang L, et al. Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial. Nat Med 2024;30:3250-3260.
3. Kieliszek M, Bano I, Zare H. A Comprehensive Review on Selenium and Its Effects on Human Health and Distribution in Middle Eastern Countries. Biol Trace Elem Res 2022;200:971-987.
4. Avery JC, Hoffmann PR. Selenium, Selenoproteins, and Immunity. Nutrients 2018;10:1203.
5. Yuan S, Mason AM, Carter P, et al. Selenium and cancer risk: Wide-angled Mendelian randomization analysis. Int J Cancer 2022;150:1134-1140.
6. Filippini T, Mazzoli R, Wise LA, Cho E, Vinceti M. Selenium exposure and risk of skin cancer: A systematic review and dose-response meta-analysis of epidemiologic evidence. J Trace Elem Med Biol 2025;90:127693.
7. Xu S, Kang Z, Li K, Li X, Zhang Y, Gao XJ. Selenium Deficiency Causes Iron Death and Inflammatory Injury Through Oxidative Stress in the Mice Gastric Mucosa. Biol Trace Elem Res 2024;202:1150-1163.
8. Zyambo K, Kelly P, Kayamba V. Evaluation of the association between gastric cancer and plasma selenium in Zambian adults: a case-control study. Ecancermedicalscience 2022;16:1351.

9. Aslan A, Karapinar HS, Kilicel F, et al. Trace element levels in serum and gastric mucosa in patients with Helicobacter pylori positive and negative gastritis. J Trace Elem Med Biol 2023;75:127108.
10. Fansiwala K, Lewis MS, Pisegna JR. Gastritis: Pathophysiology and Clinical Management. Am J Gastroenterol 2025;120:5-8.
11. Caglar E, Baysal B, Dobrucalı A. The changing pattern of upper gastrointestinal disorders by endoscopy: data of the last 40 years. Diagn Ther Endosc 2014;2014:262638.
12. Tomar VB, Karataş A, Abiyev A, et al. Gastric Cancer Risk in Patients with Intestinal Metaplasia: Long-Term Outcomes from a Large Single-Center Cohort in Türkiye. J Clin Med 2025;14:7662.
13. Steevens J, van den Brandt PA, Goldbohm RA, Schouten LJ. Selenium status and the risk of esophageal and gastric cancer subtypes: the Netherlands cohort study. Gastroenterology 2010;138:1704-1713.
14. Gong HY, He JG, Li BS. Meta-analysis of the association between selenium and gastric cancer risk. Oncotarget 2016;7:15600-15605.
15. Lin Y, Wu C, Yan W, Guo S, Liu B. Five Serum Trace Elements Associated with Risk of Cardia and Noncardia Gastric Cancer in a Matched Case-Control Study. Cancer Manag Res 2020;12:4441-4451.
16. Thrastardottir TO, Copeland VJ, Constantinou C. The Association Between the Gut Microbiome, Nutritional Habits, Antibiotics, and Gastric Cancer: a Scoping Review. Curr Nutr Rep 2022;11:19-38.
17. Shimada BK, Swanson S, Toh P, Seale LA. Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers. Biomolecules 2022;12:1581.
18. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51.
19. Tsukanov VV, Smirnova OV, Kasparov EV, et al. Dynamics of Oxidative Stress in Helicobacter pylori-Positive Patients with Atrophic Body Gastritis and Various Stages of Gastric Cancer. Diagnostics (Basel) 2022;12:1203.
20. Dolu S, Cengiz MB, Döngelli H, Gürbüz M, Arayici ME. Importance of hematological and inflammatory markers in the localization of gastric cancer. World J Gastrointest Oncol 2025;17:104455.
21. Shirani M, Pakzad R, Haddadi MH, et al. The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis. BMC Infect Dis 2023;23:543.